Welcome to our dedicated page for Timken SEC filings (Ticker: TKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for The Timken Company (NYSE: TKR), an Ohio-incorporated global technology leader in engineered bearings and industrial motion. Timken files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with other required documents.
In its periodic reports, Timken presents consolidated financial statements, segment information for its Engineered Bearings and Industrial Motion businesses, and discussions of factors affecting performance such as pricing, foreign currency translation, acquisitions, end-market demand, material and logistics costs and tariffs. These filings also include explanations of non-GAAP measures like EBITDA and adjusted EBITDA, which the company uses in managing the business.
Current reports on Form 8-K document material events, including quarterly and second-quarter earnings releases, leadership changes such as the appointment of a new president and chief executive officer and a new vice president and chief financial officer, and other significant corporate developments. Certain information in these 8-K filings is furnished rather than filed, as Timken notes in its disclosures.
Investors can also review filings that describe executive compensation and severance arrangements, board decisions on leadership roles and details of Timken’s securities registered on the New York Stock Exchange. The company has disclosed its application to cease being a reporting issuer in Ontario, Canada, while continuing to file all required materials with U.S. regulators and the NYSE.
On Stock Titan, Timken’s SEC filings are updated as they become available from EDGAR. AI-powered summaries help explain key points from lengthy documents, highlight segment trends and clarify the implications of material events, enabling users to navigate Timken’s regulatory history more efficiently.
Timken Company executive John Raymond Szarka, SVP and Chief Technology Officer, reported multiple equity transactions on February 12, 2026. He acquired 868 shares of common stock at
Szarka also received new equity awards: a grant of 1,250 time-based restricted share units that vest 25% per year and a grant of 1,850 performance-based restricted share units tied to performance criteria between
Timken EVP and CFO Michael Anthony Discenza reported equity compensation changes. On February 12, 2026, he acquired 1,510 shares of common stock at $0 from vesting performance-based restricted share units, while 421 shares were disposed of at $108.74 to cover tax obligations.
He also received new derivative awards: 5,475 time-based restricted share units that vest 25% per year and 8,200 performance-based restricted share units tied to performance between January 1, 2026 and December 31, 2028. Following these transactions, he directly held 17,585 common shares, plus the newly granted RSUs.
Timken Corporate Controller & CAO Megan Renee Lanzarotta reported multiple equity awards and related share movements dated February 12, 2026. She acquired 245 shares of common stock at $0, reflecting the vesting of previously granted performance-based restricted share units after compensation committee approval.
On the same date she received a grant of 575 time-based restricted share units, which vest 25% per year, and a separate grant of 850 performance-based restricted share units tied to performance between January 1, 2026 and December 31, 2028. The filing also shows a disposition of 84 common shares at $108.74 to cover tax liabilities, leaving her with 1,861 common shares held directly.
Timken president and CEO Lucian Boldea reported equity awards in the form of restricted share units (RSUs). On February 12, 2026, he acquired 23,500 time-based RSUs that vest 25% each year and 35,225 performance-based RSUs that depend on performance criteria measured from January 1, 2026 to December 31, 2028. Both RSU grants are derivatives tied to Timken common stock, were recorded at a price of $0 per unit, and are held as direct beneficial ownership.
The Timken Company approved a new share repurchase plan that allows it to buy back up to ten million of its outstanding common shares. The 2026 Share Purchase Plan becomes effective on March 1, 2026 and will remain in place until February 28, 2031.
The company may repurchase shares over time through open market purchases, privately negotiated transactions, accelerated share repurchases, or Rule 10b5-1 plans. This new plan replaces Timken’s prior share purchase plan, which ends on February 28, 2026.
The Timken Company reported that director James F. Palmer will retire from its board effective March 31, 2026. Palmer currently serves as Chair of the Audit Committee and is also a member of the Compensation Committee.
The company stated that his retirement is a mutual decision and is not the result of any financial or accounting issue or any disagreement with the board or the company on such matters. The transition supports the planned appointment of Sarah C. Lauber as the new Audit Committee chair.
The Timken Company reported 2025 net sales of
Backlog reached
The company highlighted progress on sustainability, cutting greenhouse gas emissions intensity by about
American Century entities reported a 4.3% passive ownership stake in The Timken Company’s common stock. American Century Investment Management, American Century Companies, and the Stowers Institute for Medical Research jointly report beneficial ownership of 2,974,175 shares, with sole voting power over 2,874,333 shares and sole dispositive power over 2,974,175 shares.
The filers state that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Timken. This amended Schedule 13G reflects their position as of the event date of 12/31/2025, below the 5% ownership threshold.
Timken Corporate Controller & CAO Megan Renee Lanzarotta reported equity compensation activity in Timken common stock. On February 10, 2026, she acquired 53 shares at $0 under a grant or award, tied to the vesting of 25% of time-based restricted share units granted on February 10, 2022.
On the same date, 18 shares were disposed of at $109.23 in a transaction coded as payment of tax liability by delivering securities. After these transactions, she directly owned 1,700 shares of Timken common stock.
Timken Chief Technology Officer John Raymond Szarka reported equity award activity in company common stock. On February 10, 2026, he acquired 168 shares of common stock at $0 per share, reflecting vesting of 25% of time-based restricted share units originally granted on February 10, 2022.
On the same date, 58 shares of common stock were disposed of at $109.23 per share to cover tax obligations through share withholding. Following these transactions, Szarka directly owned 2,843 shares of Timken common stock.